Mira Pharmaceuticals (MIRA) Profit After Tax (2022 - 2025)

Mira Pharmaceuticals has reported Profit After Tax for 4 years, with the latest figure at -$5.9 million in Q4 2025.

• Quarterly Profit After Tax fell 147.57% year-over-year to -$5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$10.4 million (down 32.44% YoY) and the FY2025 annual result came in at -$10.4 million, down 32.44% from the prior year.
• Profit After Tax slipped to -$5.9 million in Q4 2025 per MIRA's latest filing, from -$1.1 million in the prior quarter.
• Over five years, Profit After Tax peaked at -$1.1 million in Q3 2025 and troughed at -$5.9 million in Q4 2025.
• A 4-year average of -$2.4 million and a median of -$1.8 million in 2024 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2023 and 2024: Profit After Tax tumbled 328.86% in 2023, then surged 58.54% in 2024.
• Over 4 years, Profit After Tax stood at -$1.3 million in 2022, then tumbled by 328.86% to -$5.8 million in 2023, then soared by 58.54% to -$2.4 million in 2024, then tumbled by 147.57% to -$5.9 million in 2025.
• According to Business Quant data, Profit After Tax over the past three periods registered -$5.9 million, -$1.1 million, and -$1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.